Physician profile
Shubnum Singh
NPI 1205069838
$2,530.94
in general payments reported to CMS, 2019-2025
17 companies · $50.39 in 2025
The $50.39 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $436 · 2022: $982 · 2023: $762 · 2024: $300 · 2025: $50.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $529.50 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $403.48 | 2021-2024 | Accolade Sr, Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.70 | 2021-2023 | Jardiance |
| Pfizer INC. | $209.12 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $157.22 | 2021-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $156.64 | 2021-2024 | Verquvo |
| Edwards Lifesciences Corporation | $153.39 | 2022-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $120.20 | 2021-2024 | |
| Amgen INC. | $116.39 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $115.66 | 2022-2024 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $112.63 | 2022-2023 | Optimizer |
| Abbott Laboratories | $94.14 | 2024 | Jot Dx |
| Kiniksa Pharmaceuticals, LTD. | $33.55 | 2021 | |
| Cvrx, INC. | $31.25 | 2023 | Barostim Neo System |
| Amarin Pharma, INC. | $26.86 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $17.16 | 2025 | |
| Esperion Therapeutics, INC. | $13.05 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shubnum Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.